FILTER
FILTERED INTERVIEW RESULTS
Renold Capocasale
CEO, FLOWMETRIC INC.
FlowMetric offers scientific analysis using Flow Cytometry to advance drug development.
Dirk van Peteghem
UPS VICE PRESIDENT, GLOBAL HEALTHCARE STRATEGY
UPS recently improved its offering to the pharmaceutical industry with the acquisition of Marken.
Scott Cubbler
COO LIFE SCIENCES & HEALTHCARE, GLOBAL, DHL SUPPLY CHAIN
DHL Supply Chain explains how the company keeps pace with changes such as recent demand for more biosimilars and personalized drugs.
Chris Molloy
SENIOR VICE PRESIDENT, OFFICE OF RESEARCH AND ECONOMIC DEVELOPMENT, RUTGERS UNIVERSITY
Rutgers University is a leading national research university that works alongside its corporate neighbors to foster developments in the health sector.
Debbie Hart
PRESIDENT AND CEO, BIONJ
BioNJ is involved in ensuring that New Jersey retains its leading position as a center of global life sciences by facilitating the industry’s development.
Gil Roth
THE PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
The PBOA effectively promotes Contract Manufacturing organizations and protects their interests.
Dean J. Paranicas
PRESIDENT AND CEO, HEALTHCARE INSTITUTE OF NEW JERSEY (HINJ)
HealthCare Institute of New Jersey endeavors to ensure a favorable environment so that New Jersey remains at the center of global life science research.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
